Published in J Immunol on October 15, 2001
Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol (2008) 9.25
Protective immune mechanisms in helminth infection. Nat Rev Immunol (2007) 5.66
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med (2007) 5.65
Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother (2005) 2.87
Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res (2010) 2.48
Alternatively activated macrophages in helminth infections. Curr Opin Immunol (2007) 2.41
Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood (2008) 2.16
Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology (2012) 2.09
IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med (2005) 2.07
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev (2004) 1.95
Alternatively activated macrophages in infection and autoimmunity. J Autoimmun (2009) 1.83
Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol (2010) 1.66
Immunology of parasitic helminth infections. Infect Immun (2002) 1.62
Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J (2008) 1.49
Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis. Infect Immun (2004) 1.31
Trauma equals danger--damage control by the immune system. J Leukoc Biol (2012) 1.15
The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo. Immunology (2008) 1.08
Plasticity of Ly-6C(hi) myeloid cells in T cell regulation. J Immunol (2011) 1.07
Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways. Nat Med (2012) 1.07
Helminth infection in populations undergoing epidemiological transition: a friend or foe? Semin Immunopathol (2012) 1.01
Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells. Chembiochem (2008) 1.00
Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma. Invest Ophthalmol Vis Sci (2011) 0.97
Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding. Am J Clin Nutr (2012) 0.96
Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells. Semin Cancer Biol (2012) 0.95
Gr1+IL-4-producing innate cells are induced in response to Th2 stimuli and suppress Th1-dependent antibody responses. Int Immunol (2008) 0.94
LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction. Clin Diagn Lab Immunol (2005) 0.94
IL-4Ralpha-independent expression of mannose receptor and Ym1 by macrophages depends on their IL-10 responsiveness. PLoS Negl Trop Dis (2010) 0.94
Peritoneal macrophages suppress T-cell activation by amino acid catabolism. Immunology (2006) 0.90
Characteristics of suppressor macrophages induced by mycobacterial and protozoal infections in relation to alternatively activated M2 macrophages. Clin Dev Immunol (2012) 0.90
Schistosome glycoconjugates in host-parasite interplay. Glycoconj J (2001) 0.89
Autoantigen immunization at different sites reveals a role for anti-inflammatory effects of IFN-gamma in regulating susceptibility to experimental autoimmune encephalomyelitis. J Immunol (2009) 0.88
Regulation of type 1 diabetes, tuberculosis, and asthma by parasites. J Mol Med (Berl) (2009) 0.85
Nitrosothiols in the immune system: signaling and protection. Antioxid Redox Signal (2012) 0.84
Clinical applications of bioactive milk components. Nutr Rev (2015) 0.83
Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects. Cancer Immunol Immunother (2012) 0.83
Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses. Immunology (2009) 0.83
Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients. Clin Exp Immunol (2015) 0.81
Phenotype, development, and biological function of myeloid-derived suppressor cells. Oncoimmunology (2015) 0.80
Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsis. Infect Immun (2010) 0.80
Immunomodulatory glycan lacto-N-fucopentaose III requires clathrin-mediated endocytosis to induce alternative activation of antigen-presenting cells. Infect Immun (2014) 0.79
Novel O-linked methylated glycan antigens decorate secreted immunodominant glycoproteins from the intestinal nematode Heligmosomoides polygyrus. Int J Parasitol (2015) 0.79
Peritoneal T lymphocyte regulation by macrophages. Immunobiology (2010) 0.79
Helminth parasites alter protection against Plasmodium infection. Biomed Res Int (2014) 0.79
Modulation of innate antigen-presenting cell function by pre-patent schistosome infection. PLoS Negl Trop Dis (2013) 0.78
Treatment with Cestode Parasite Antigens Results in Recruitment of CCR2+ Myeloid Cells, the Adoptive Transfer of Which Ameliorates Colitis. Infect Immun (2016) 0.78
A Dirofilaria immitis polyprotein up-regulates nitric oxide production. Infect Immun (2002) 0.78
Comparative studies on the roles of mediator molecules in expression of the suppressor activity of Mycobacterium avium complex-induced immunosuppressive macrophages against T cell and B cell mitogenic responses. Clin Exp Immunol (2006) 0.76
The Phenotype and Function of Myeloid-derived Suppressor Cells Induced by Porphyromonas gingivalis Infection. Infect Immun (2017) 0.75
Clinical findings associated with acute proximal deep vein thrombosis: a basis for quantifying clinical judgment. Am J Med (1990) 1.93
Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci U S A (1994) 1.89
Schistosoma mansoni. Anti-egg monoclonal antibodies protect against cercarial challenge in vivo. J Exp Med (1984) 1.51
Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J Immunol (1999) 1.47
Lacto-N-fucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol (2001) 1.45
Intranasal application of purified protein derivative suppresses the initiation but not the exacerbation of allergic rhinitis in mice. Clin Exp Allergy (2002) 1.45
Penetrating esophageal injuries: multicenter study of the American Association for the Surgery of Trauma. J Trauma (2001) 1.19
A Schistosoma mansoni epitope recognized by a protective monoclonal antibody is identical to the stage-specific embryonic antigen 1. Proc Natl Acad Sci U S A (1990) 1.16
Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine (2001) 1.14
B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol (1996) 1.12
T and B cell epitope mapping of SM23, an integral membrane protein of Schistosoma mansoni. J Immunol (1992) 1.11
B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol (1997) 1.07
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun (2001) 1.06
T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol (1994) 1.05
A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med (1990) 1.03
Lewis(x)-containing oligosaccharide attenuates schistosome egg antigen-induced immune depression in human schistosomiasis. Hum Immunol (2000) 1.00
Control of reflex detrusor activity in normal and spinal injured non-human primates. J Urol (1983) 0.97
Isotype responses to candidate vaccine antigens in protective sera obtained from mice vaccinated with irradiated cercariae of Schistosoma mansoni. Infect Immun (1993) 0.91
Schistosoma mansoni: genetic restriction and cytokine profile of the CD4 + T helper cell response to dominant epitope peptide of major egg antigen Sm-p40. Exp Parasitol (1998) 0.90
Students' sexual behavior, knowledge, and attitudes relating to the acquired immunodeficiency syndrome. J Gen Intern Med (1988) 0.90
Urethral sphincter mechanisms. Urol Clin North Am (1979) 0.90
Differential role of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice. Am J Respir Crit Care Med (2001) 0.90
Interleukin-4-independent production of Th2 cytokines by nasal lymphocytes and nasal eosinophilia in murine allergic rhinitis. Allergy (2000) 0.89
Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. J Infect Dis (1996) 0.89
A cloned ATP:guanidino kinase in the trematode Schistosoma mansoni has a novel duplicated structure. J Biol Chem (1990) 0.89
The protective immunity of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase in infected BALB/C mice. Southeast Asian J Trop Med Public Health (2004) 0.88
Evidence that a protective membrane epitope is involved in early but not late phase immunity in Schistosoma mansoni. J Immunol (1987) 0.87
Soluble intercellular adhesion molecules in human schistosomiasis: correlations with disease severity and decreased responsiveness to egg antigens. Infect Immun (1994) 0.87
Protective immunity induced with 23 kDa membrane protein dna vaccine of Schistosoma japonicum Chinese strain in infected C57BL/6 mice. Southeast Asian J Trop Med Public Health (2003) 0.87
Schistosoma japonicum triose-phosphate isomerase plasmid DNA vaccine protects pigs against challenge infection. Parasitology (2006) 0.87
Candidate vaccine antigens that stimulate the cellular immune response of mice vaccinated with irradiated cercariae of Schistosoma mansoni. J Immunol (1993) 0.86
Failure of schistosomiasis to significantly decrease testosterone levels in Brazilian men. Am J Trop Med Hyg (1994) 0.85
A re-evaluation of studies on the distribution of glyoxalases in animal and tumour tissues. Int J Biochem (1978) 0.85
Electromyographic evaluation of sphincter function and dysfunction. Urol Clin North Am (1979) 0.85
Interleukin-12 and -10 and gamma interferon regulate polyclonal and ligand-specific expansion of murine B-1 cells. Infect Immun (1996) 0.85
The irradiated cercariae vaccine model: looking on the bright side of radiation. Parasitol Today (1995) 0.84
Schistosoma mansoni: detection by monoclonal antibody of a 22,000-dalton surface membrane antigen which may be blocked by host molecules on lung stage parasites. J Immunol (1985) 0.84
Orthopedic medical malpractice: an attorney's perspective. Am J Orthop (Belle Mead NJ) (2000) 0.84
Purification and immunochemical characterization of a 22 kilodalton surface antigen from Schistosoma mansoni. Mol Biochem Parasitol (1988) 0.84
Identification by monoclonal antibody of a major (28 kDa) surface membrane antigen of Schistosoma mansoni. Mol Biochem Parasitol (1985) 0.84
Major surgery to manage definitively severe complications of salvage cryotherapy for prostate cancer. J Urol (2000) 0.83
Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines. Parasite Immunol (2005) 0.83
Candidate vaccine antigens identified by antibodies from mice vaccinated with 15- or 50-kilorad-irradiated cercariae of Schistosoma mansoni. Infect Immun (1993) 0.83
The cell-mediated response to schistosomal antigens at the clonal level. III. Identification of soluble egg antigens recognized by cloned specific granulomagenic murine CD4+ Th1-type lymphocytes. J Immunol (1993) 0.82
Comparison of irradiated-cercaria schistosome vaccine models that use 15- and 50-kilorad doses: the 15-kilorad dose gives greater protection, smaller liver sizes, and higher gamma interferon levels after challenge. Infect Immun (1992) 0.82
Adrenergic control of lipolysis and metabolic responses in obesity. Horm Metab Res (1986) 0.82
Analysis of the immune response elicited by a multiple antigen peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni. Parasite Immunol (1997) 0.82
Monoclonal anti-idiotypic and anti-anti-idiotypic antibodies from mice immunized with a protective monoclonal antibody against Schistosoma mansoni. J Immunol (1988) 0.82
Oral administration of schistosome egg antigens and insulin B-chain generates and enhances Th2-type responses in NOD mice. Clin Immunol Immunopathol (1998) 0.82
Characterization of protective and non-protective surface membrane carbohydrate epitopes of Schistosoma mansoni. Mem Inst Oswaldo Cruz (1987) 0.82
Strain-dependent induction of allergic rhinitis without adjuvant in mice. Allergy (1999) 0.81
Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. J Urol (2001) 0.81
[Protective effects of co-immunization with SjCTPI-Hsp70 and interleukin-12 DNA vaccines against Schistosoma japonicum challenge infection in water buffalo]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2006) 0.80
The ability of mouse monoclonal antibodies to direct the cytotoxic function of cytokine-activated human eosinophils. Hybridoma (1990) 0.80
Lacto-N-fucopentaose III (Lewis x), a target of the antibody response in mice vaccinated with irradiated cercariae of Schistosoma mansoni. Infect Immun (1996) 0.79
Schistosoma mansoni triose phosphate isomerase peptide MAP4 is able to trigger naïve donor immune response towards a type-1 cytokine profile. Scand J Immunol (2008) 0.78
Schistosoma mansoni hexokinase: cDNA cloning and immunogenicity studies. Exp Parasitol (1995) 0.78
Regulation of schistosome egg granuloma formation: host-soluble L-selectin enters tissue-trapped eggs and binds to carbohydrate antigens on surface membranes of miracidia. Infect Immun (1996) 0.78
Naïve donor responses to Schistosoma mansoni soluble egg antigens. Scand J Immunol (2007) 0.78
The cell-mediated response to schistosomal antigens at the clonal level: development and characterization of a panel of egg antigen-specific murine T cell clones. Eur J Immunol (1992) 0.77
Involvement of carbohydrate on phospholipase A2, a bee-venom allergen, in in vivo antigen-specific IgE synthesis in mice. Allergy (1999) 0.76
Does yohimbine act as a slimming drug? Isr J Med Sci (1991) 0.76
Generation of antigen-specific cytotoxic T lymphocytes and regulation of cytokine production takes place in the absence of CD3zeta. Int Immunol (1999) 0.76
[Protective immunity induced by 23 kDa membrane protein DNA vaccine of Schistosoma japonicum Chinese strain in mice]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2001) 0.75
Heterogeneity of antigen-specific CD4+ T cell clones from a patient with Schistosomiasis mansoni. Parasite Immunol (1994) 0.75
Tirilazad mesylate improve water immersion stress induced decrease in erythrocyte deformability in the rats. Med Sci Monit (2001) 0.75
[Generation and immunochemical characterization of an anti-egg monoclonal antibody specific to Schistosoma japonicum]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (1992) 0.75
[The role and mechanism of lysosomal acid lipase activity]. Przegl Lek (1988) 0.75
The antecubital fossa fistula. Clin Nephrol (1976) 0.75
[Role and mechanism of lipoprotein lipase activity in lipoprotein metabolism]. Przegl Lek (1987) 0.75
[Effect of low doses of lead and cadmium on glyoxalase I and glyoxalase II activities of the liver and brain of rats]. Med Pr (1984) 0.75
[Effect of adrenergic stimulation on lipolysis in obese and lean women in the in vitro conditions]. Pol Arch Med Wewn (1988) 0.75
[Glyoxalases in normal and neoplastic tissues (author's transl)]. Przegl Lek (1980) 0.75
[Glyoxalase enzyme system (author's transl)]. Postepy Biochem (1980) 0.75
Synthesis, analysis and mutagenic activity of N-nitroso derivatives of glycosylamines and Amadori compounds: nitrosated model substances for the early Maillard reaction products. IARC Sci Publ (1987) 0.75
Lipid profiles in Polish adolescents from high- and low-risk families: tracking unfavourable lipid levels over a one-year period. Acta Paediatr (2000) 0.75
Synthesis of S-lactoyl-glutathione using glyoxalase I bound to sepharose 4B. Experientia (1976) 0.75
[Cellular and extracellular lipid binding]. Przegl Lek (1988) 0.75
The separation of glyoxalase I and glyoxalase II by paper electrophoresis. J Chromatogr (1976) 0.75
Schistosoma mansoni: molecular characterization of a tegumental Ca-ATPase (SMA3). Exp Parasitol (2001) 0.75
Performance of Americans and israelis with cerebrovascular accident on the Loewenstein Occupational Therapy Cognitive Assessment (LOTCA). Am J Occup Ther (1995) 0.75
[Role of viruses in pathogenesis of atherosclerosis]. Wiad Lek (1994) 0.75
[Effect of toxohormone, endogenic or isolated from melanoma, on the activity of liver ferrochelatase in the Syrian hamster]. Patol Pol (1980) 0.75
Further studies on liver glyoxalase I and glyoxalase II. Activity in mice bearing sarcoma 180 and L1210 leukemia. Neoplasma (1978) 0.75
[Biosynthesis of liver porphyrins in the Syrian hamster under the effect of toxohormone, endogenic or isolated from melanoma]. Patol Pol (1980) 0.75
Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity. Int J Gynaecol Obstet (2006) 0.75
[Evaluation of the effect of mazindol on the metabolism and lipolysis in obese women]. Pol Arch Med Wewn (1987) 0.75
Synthesis, structure-activity relationships and a reaction mechanism for mutagenic N-nitroso derivatives of glycosylamines and Amadori compounds--model substances for N-nitrosated early Maillard reaction products. Food Chem Toxicol (1987) 0.75
Characterization of isoelectric point (pI) fractions of soluble egg antigen of Schistosoma japonicum. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (1994) 0.75
[Use of yohimbine, an alpha-adrenolytic drug, in obesity]. Pol Arch Med Wewn (1986) 0.75
The effect of weight reduction on blood pressure and metabolic responses to physical exercise in obese women. Mater Med Pol (1988) 0.75
[Study of toxohormone properties by the proteolytic enzyme digestion method]. Patol Pol (1980) 0.75
[Activity of glyoxalase and glyoxalase II under the effect of toxohormone from melanoma]. Patol Pol (1980) 0.75
Activity of erythrocytic glycoxalases I and II in bearers of certain neoplasms. Acta Med Pol (1989) 0.75
Red blood cells deformability and oxidative stress in acute pancreatitis. Clin Hemorheol Microcirc (2002) 0.75
Construction of a low pressure reservoir and achievement of continence after "diversion" and in end stage vesical dysfunction. J Urol (1987) 0.75
[Vitamins and arteriosclerosis]. Pol Arch Med Wewn (1992) 0.75